Heparanase multiple effects in cancer (Q38214970)

31 August 2017

title

Heparanase multiple effects in cancer (English)

1 reference

31 August 2017

Benjamin Brenner

1 reference

31 August 2017

Yona Nadir

1 reference

31 August 2017

publication date

1 May 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

133 Suppl 2

1 reference

31 August 2017

page(s)

S90-4

1 reference

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Human heparanase-1 gene expression in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase protein and gene expression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Expression of three extracellular matrix degradative enzymes in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase-1 expression is associated with the metastatic potential of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase expression in human leukemias is restricted to acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Human heparanase nuclear localization and enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase as mediator of angiogenesis: mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Syndecan-1: a dynamic regulator of the myeloma microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Soluble syndecan-1 promotes growth of myeloma tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase induces VEGF C and facilitates tumor lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Molecular mechanisms of lymphangiogenesis in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Identification of active-site residues of the pro-metastatic endoglycosidase heparanase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

The prothrombotic state in cancer: pathogenic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase induces tissue factor expression in vascular endothelial and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

An assay to evaluate heparanase procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase procoagulant activity is elevated in women using oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Tissue factor pathway inhibitor: structure, biology and involvement in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Elevated TFPI in malignant disease: relation to cancer type and hypercoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Elevated plasma levels of the factor Xa-TFPI complex in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

An ELISA method for the detection and quantification of human heparanase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

The impact of heparanese and heparin on cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients from Northern Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase gene haplotype (CGC) is associated with stage of disease in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

Heparanase Expression Correlates with Invasion and Poor Prognosis in Gastric Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950015-1

7 January 2021

10.1016/S0049-3848(14)50015-1

Identifiers

DOI

1 reference

release_ipiyvi7u6bd37fj656dkmca74i

31 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ipiyvi7u6bd37fj656dkmca74i

24 November 2022

mapped directly with Wikidata item

1 reference